Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

Journal of Diabetes Science and Technology

Volumn 12, Issue 1, 2018, Pages 183-189

  Mannucci, Edoardo ^a   Antenore, Alessandro ^a   Giorgino, Francesco ^b   Scavini, Marina ^c  

^a Careggi Teaching Hospital   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

meta analysis; non insulin treated; self monitoring of blood glucose; treatment algorithms; type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ASSESSMENT; DIET; HUMAN; MEDICATION COMPLIANCE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; REVIEW; STRUCTURED BLOOD GLUCOSE MONITORING; UNSTRUCTURED BLOOD GLUCOSE MONITORING; ALGORITHM; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; GLYCATED HEMOGLOBIN A; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85042765229     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296817719290     Document Type: Review

References (30)

1. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(suppl 1):S14-S80.
2. International Diabetes Federation. IDF guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Available at: http://www.idf.org/guidelines/self-monitoring. Accessed May 2, 2014.
3. Ceriello A, Barkai L, Christiansen JS. Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract. 2012;98:5-10.
4. Raz I, Riddle MC, Rosenstock J. Personalized management of hyperglycemia in type 2 diabetes: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2013;36:1779-1788.
5. International Diabetes Federation. 2011 guidelines for management of postmeal glucose in diabetes. http://www.idf.org/sites/default/files/postmeal%20glucose%20guidelines.pdf. Accessed May 2, 2014.
6. Clar C, Barnard K, Cummins E. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14:1-140.
7. Sarol JN, Jr Nicodemus NA, Jr Tan KM, Grava MB., Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin. 2005:21:173-184.
8. Towfigh A, Romanova M, Weinreb JE. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008;14:468-475.
9. Poolsup N, Suksomboon N, Rattanasookchit S., Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11:775-784.
10. Malanda UL, Welschen LM, Riphagen II. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012;1:CD005060. doi:10.1002/14651858.CD005060.pub3.
11. Farmer AJ, Perera R, Ward A. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012;344:e486.
12. Zhu H, Zhu Y, Leung SW., Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: a meta-analysis of randomised controlled trials. BMJ Open. 2016;6(9):e010524.
13. Parkin CG, Buskirk A, Hinnen DA, Axel-Schweitzer M., Results that matter: structured vs.unstructured self-monitoring of blood glucose in type 2 diabetes. Diabetes Res Clin Pract 2012;97:6-15.
14. Liberati A, Altman DG, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-W94.
15. Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 2006;17:1-12.
16. Egger M, Davey Smith G, Schneider M, Minder C., Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
17. Begg CB, Mazumdar M., Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
18. Schwedes U, Siebolds M, Mertes G., Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25:1928-1932.
19. Guerci B, Drouin P, Grangé V. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29:587-594.
20. Davidson MB, Castellanos M, Kain D, Duran P., The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118:422-425.
21. Farmer A, Wade A, Goyder E. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:132.
22. O’Kane MJ, Bunting B, Copeland M, Coates VE., Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008;336:1174-1177.
23. Barnett AH, Krentz AJ, Strojek K. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab. 2008;10:1239-1247.
24. Kleefstra N, Hortensius J, Logtenberg SJJ. Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC). Neth J Med. 2010;68:311-316.
25. Franciosi M, Lucisano G, Pellegrini F. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med. 2011;28:789-796.
26. Duran A, Martin P, Runkle I. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2:203-211.
27. Polonsky WH, Fisher L, Schikman CH. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34:262-267.
28. Scavini M, Bosi E, Ceriello A. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention. Acta Diabetol. 2013;50:663-672.
29. Bosi E, Scavini M, Ceriello A. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA Randomized Trial. Diabetes Care. 2013;36:2887-2894.
30. Pickup JC., The evidence base for diabetes technology: appropriate and inappropriate meta-analysis. J Diabetes Sci Technol. 2013;7:1567-1574.